• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体和CD8 + T细胞对西尼罗河脑炎病毒疫苗免疫的相对贡献。

The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus.

作者信息

Shrestha Bimmi, Ng Terry, Chu Hsien-Jue, Noll Michelle, Diamond Michael S

机构信息

Department of Medicine, 660 S. Euclid Avenue, Box 8051, Washington University School of Medicine, St. Louis, MO 63110, United States.

出版信息

Vaccine. 2008 Apr 7;26(16):2020-33. doi: 10.1016/j.vaccine.2008.02.009. Epub 2008 Feb 20.

DOI:10.1016/j.vaccine.2008.02.009
PMID:18339459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2465211/
Abstract

West Nile virus (WNV) is a mosquito borne, neurotropic flavivirus that causes a severe central nervous system (CNS) infection in humans and animals. Although commercial vaccines are available for horses, none is currently approved for human use. In this study, we evaluated the efficacy and mechanism of immune protection of two candidate WNV vaccines in mice. A formalin-inactivated WNV vaccine induced higher levels of specific and neutralizing antibodies compared to a DNA plasmid vaccine that produces virus-like particles. Accordingly, partial and almost complete protection against a highly stringent lethal intracranial WNV challenge were observed in mice 60 days after single dose immunization with the DNA plasmid and inactivated virus vaccines, respectively. In mice immunized with a single dose of DNA plasmid or inactivated vaccine, antigen-specific CD8(+) T cells were induced and contributed to protective immunity as acquired or genetic deficiencies of CD8(+) T cells lowered the survival rates. In contrast, in boosted animals, WNV-specific antibody titers were higher, survival rates after challenge were greater, and an absence of CD8(+) T cells did not appreciably affect mortality. Overall, our experiments suggest that in mice, both inactivated WNV and DNA plasmid vaccines are protective after two doses, and the specific contribution of antibody and CD8(+) T cells to vaccine immunity against WNV is modulated by the prime-boost strategy.

摘要

西尼罗河病毒(WNV)是一种由蚊子传播的嗜神经黄病毒,可导致人类和动物发生严重的中枢神经系统(CNS)感染。虽然有用于马匹的商业疫苗,但目前尚无获批用于人类的疫苗。在本研究中,我们评估了两种候选WNV疫苗在小鼠中的免疫保护效果和机制。与产生病毒样颗粒的DNA质粒疫苗相比,福尔马林灭活的WNV疫苗诱导产生了更高水平的特异性中和抗体。因此,在用DNA质粒疫苗和灭活病毒疫苗单剂量免疫60天后的小鼠中,分别观察到了对高度严格的致死性颅内WNV攻击的部分保护和几乎完全保护。在用单剂量DNA质粒或灭活疫苗免疫的小鼠中,诱导产生了抗原特异性CD8(+) T细胞,并且由于CD8(+) T细胞的获得性或遗传性缺陷降低了存活率,所以这些细胞对保护性免疫有贡献。相比之下,在加强免疫的动物中,WNV特异性抗体滴度更高,攻击后的存活率更高,并且缺乏CD8(+) T细胞对死亡率没有明显影响。总体而言,我们的实验表明,在小鼠中,灭活WNV疫苗和DNA质粒疫苗在两剂接种后均具有保护作用,并且抗体和CD8(+) T细胞对WNV疫苗免疫的具体贡献受初免-加强策略的调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b5/2465211/0cc55b789fb2/nihms45398f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b5/2465211/2d4de9aa62f0/nihms45398f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b5/2465211/be17a3a5db7b/nihms45398f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b5/2465211/adef3830ce76/nihms45398f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b5/2465211/0cc55b789fb2/nihms45398f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b5/2465211/2d4de9aa62f0/nihms45398f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b5/2465211/be17a3a5db7b/nihms45398f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b5/2465211/adef3830ce76/nihms45398f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18b5/2465211/0cc55b789fb2/nihms45398f4.jpg

相似文献

1
The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus.抗体和CD8 + T细胞对西尼罗河脑炎病毒疫苗免疫的相对贡献。
Vaccine. 2008 Apr 7;26(16):2020-33. doi: 10.1016/j.vaccine.2008.02.009. Epub 2008 Feb 20.
2
Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge.采用DNA初免-蛋白加强策略用西尼罗河病毒E蛋白对小鼠进行疫苗接种可刺激细胞介导的免疫反应,并保护小鼠免受致死性攻击。
PLoS One. 2014 Feb 4;9(2):e87837. doi: 10.1371/journal.pone.0087837. eCollection 2014.
3
A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.一种编码西尼罗河病毒 E 蛋白的 DNA 疫苗具有保护作用,并且可以通过重组结构域 DIII 进行加强。
Vaccine. 2011 Aug 26;29(37):6352-7. doi: 10.1016/j.vaccine.2011.04.116. Epub 2011 May 17.
4
An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody.含 delta 菊糖佐剂的灭活细胞培养乙型脑炎疫苗(JE-ADVAX)通过交叉保护记忆 B 细胞和中和抗体提供针对西尼罗河脑炎的强大异源保护。
J Virol. 2013 Sep;87(18):10324-33. doi: 10.1128/JVI.00480-13. Epub 2013 Jul 17.
5
The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys.灭活西尼罗河疫苗(WN-VAX)在小鼠和猴子身上的功效。
Virol J. 2015 Apr 9;12:54. doi: 10.1186/s12985-015-0282-8.
6
Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.携带西尼罗河病毒包膜抗原的改良安卡拉痘苗病毒候选疫苗的免疫原性和保护效力。
Vaccine. 2016 Apr 7;34(16):1915-26. doi: 10.1016/j.vaccine.2016.02.042. Epub 2016 Mar 2.
7
A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.一种西尼罗河病毒(WNV)重组金丝雀痘病毒疫苗可在马体内引发WNV特异性中和抗体和细胞介导的免疫反应。
Vet Immunol Immunopathol. 2008 Jun 15;123(3-4):230-9. doi: 10.1016/j.vetimm.2008.02.002. Epub 2008 Feb 16.
8
A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.植物源疫苗可预防小鼠感染致死性西尼罗河病毒,而不增强寨卡病毒或登革热病毒的感染力。
Vaccine. 2018 Mar 27;36(14):1846-1852. doi: 10.1016/j.vaccine.2018.02.073. Epub 2018 Feb 26.
9
Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection.单链 HLA-A2 MHC 三聚体与免疫显性肽结合可引发针对致命西尼罗河病毒感染的保护性 T 细胞免疫。
J Immunol. 2010 Apr 15;184(8):4423-30. doi: 10.4049/jimmunol.0903955. Epub 2010 Mar 8.
10
Serum neutralising antibody titres against a lineage 2 neuroinvasive West Nile Virus strain in response to vaccination with an inactivated lineage 1 vaccine in a European endemic area.在一个欧洲流行地区,针对 1 型神经侵袭性西尼罗河病毒株灭活疫苗接种后,对 2 型神经侵袭性西尼罗河病毒株的血清中和抗体滴度。
Vet Immunol Immunopathol. 2020 Sep;227:110087. doi: 10.1016/j.vetimm.2020.110087. Epub 2020 Jun 20.

引用本文的文献

1
Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs.病毒样颗粒 (VLPs) 与树突状细胞 (DCs) 模式识别受体 (PRRs) 的相互作用:更好地工程化 VLPs。
Front Immunol. 2020 Jun 9;11:1100. doi: 10.3389/fimmu.2020.01100. eCollection 2020.
2
Current Understanding of West Nile Virus Clinical Manifestations, Immune Responses, Neuroinvasion, and Immunotherapeutic Implications.对西尼罗河病毒临床表现、免疫反应、神经侵袭及免疫治疗意义的当前认识
Pathogens. 2019 Oct 16;8(4):193. doi: 10.3390/pathogens8040193.
3
Twenty Years of Progress Toward West Nile Virus Vaccine Development.

本文引用的文献

1
Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus.用西尼罗河病毒包膜结构域III进行免疫可保护小鼠免受同源和异源病毒的致死性感染。
Vaccine. 2008 Jan 10;26(2):153-7. doi: 10.1016/j.vaccine.2007.10.055. Epub 2007 Nov 20.
2
Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection.对致死性西尼罗河病毒感染作出反应的CD8(+) T细胞的保护能力和表位特异性
Eur J Immunol. 2007 Jul;37(7):1855-63. doi: 10.1002/eji.200737196.
3
Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.
西尼罗河病毒疫苗研发 20 年进展
Viruses. 2019 Sep 5;11(9):823. doi: 10.3390/v11090823.
4
Identification of Protective CD8 T Cell Responses in a Mouse Model of Zika Virus Infection.寨卡病毒感染小鼠模型中保护性 CD8 T 细胞应答的鉴定。
Front Immunol. 2019 Jul 17;10:1678. doi: 10.3389/fimmu.2019.01678. eCollection 2019.
5
Replication-Defective West Nile Virus with NS1 Deletion as a New Vaccine Platform for Flavivirus.复制缺陷型西尼罗河病毒 NS1 缺失突变体作为黄病毒新型疫苗平台。
J Virol. 2019 Aug 13;93(17). doi: 10.1128/JVI.00720-19. Print 2019 Sep 1.
6
Small Interfering RNA-Mediated Control of Virus Replication in the CNS Is Therapeutic and Enables Natural Immunity to West Nile Virus.小干扰 RNA 介导的中枢神经系统病毒复制控制具有治疗作用,并使机体对西尼罗河病毒产生天然免疫力。
Cell Host Microbe. 2018 Apr 11;23(4):549-556.e3. doi: 10.1016/j.chom.2018.03.001. Epub 2018 Mar 29.
7
CD8 T cells protect adult naive mice from JEV-induced morbidity via lytic function.CD8 T细胞通过裂解功能保护成年未感染小鼠免受日本脑炎病毒(JEV)诱导的发病。
PLoS Negl Trop Dis. 2017 Feb 2;11(2):e0005329. doi: 10.1371/journal.pntd.0005329. eCollection 2017 Feb.
8
Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine.一种过氧化氢灭活西尼罗河病毒疫苗的临床前开发。
Vaccine. 2017 Jan 5;35(2):283-292. doi: 10.1016/j.vaccine.2016.11.080. Epub 2016 Dec 3.
9
Interleukin-17A Promotes CD8+ T Cell Cytotoxicity To Facilitate West Nile Virus Clearance.白细胞介素-17A促进CD8 + T细胞的细胞毒性以促进西尼罗河病毒清除。
J Virol. 2016 Dec 16;91(1). doi: 10.1128/JVI.01529-16. Print 2017 Jan 1.
10
An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.西尼罗河病毒感染治疗与预防的当前方法概述
Methods Mol Biol. 2016;1435:249-91. doi: 10.1007/978-1-4939-3670-0_19.
抗原特异性细胞毒性T淋巴细胞可预防致死性西尼罗河病毒脑炎。
Eur J Immunol. 2007 Jul;37(7):1845-54. doi: 10.1002/eji.200737192.
4
Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.西尼罗河病毒重组包膜结构域III蛋白免疫可诱导特异性免疫反应并提供针对西尼罗河病毒感染的保护。
J Immunol. 2007 Mar 1;178(5):2699-705. doi: 10.4049/jimmunol.178.5.2699.
5
Incidence and effects of West Nile virus infection in vaccinated and unvaccinated horses in California.加利福尼亚州接种疫苗和未接种疫苗马匹中西尼罗河病毒感染的发病率及影响
Vet Res. 2007 Jan-Feb;38(1):109-16. doi: 10.1051/vetres:2006045.
6
Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters.在神经元感染后给予的针对西尼罗河病毒包膜蛋白的人源化单克隆抗体可保护仓鼠免受致死性脑炎。
J Infect Dis. 2006 Nov 1;194(9):1300-8. doi: 10.1086/508293. Epub 2006 Sep 22.
7
CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system.清除中枢神经系统中的西尼罗河病毒需要CD4 + T细胞反应。
J Virol. 2006 Dec;80(24):12060-9. doi: 10.1128/JVI.01650-06. Epub 2006 Oct 11.
8
Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein.西尼罗河病毒包膜蛋白I和II结构域上的抗体识别与中和决定簇
J Virol. 2006 Dec;80(24):12149-59. doi: 10.1128/JVI.01732-06. Epub 2006 Oct 11.
9
Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaques.恒河猴对登革2型DNA疫苗与两种登革2型蛋白疫苗组合的抗体反应特征
J Virol. 2006 Oct;80(19):9577-85. doi: 10.1128/JVI.00284-06.
10
Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.西尼罗河病毒感染的发病机制:毒力、固有免疫和适应性免疫以及病毒逃避之间的平衡。
J Virol. 2006 Oct;80(19):9349-60. doi: 10.1128/JVI.01122-06.